WMSA
KYNB

Weiss Multi-Strategy Advisers’s Kyntra Bio KYNB Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-600
Closed -$694K – 547
2018
Q4 		$694K Buy
+600
New +$674K 0.03% 326

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weiss Multi-Strategy Advisers's KYNB Position: Q1 2021 in Review

Weiss Multi-Strategy Advisers sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 904 shares — an estimated $839K sold.

Weiss Multi-Strategy Advisers first reported a position in KYNB in Q3 2017 and held it in 13 quarters. The position peaked at $6.46M in Q3 2017. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 904 Kyntra Bio shares in Q1 2021, an estimated $839K.
  • Weiss Multi-Strategy Advisers first reported a position in Kyntra Bio in Q3 2017 and held it in 13 quarters.
  • Weiss Multi-Strategy Advisers's Kyntra Bio position peaked at $6.46M in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2021, filed 14 May 2021.